FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine - Hallo friendsLET'S HEALTHY LIFE, In the article you read this time with the title FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article cough, Article diabetes, Article diseases, Article in general, Article Phytotherapy, Article skin diseases, We write this you can understand. Alright, good read.

Title : FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine
link : FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine

FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine

In continuation of my update on Tosymra (sumatriptan)

Dr. Reddy’s Laboratories Ltd. and its subsidiary, Promius Pharma, LLC today announced the approval of Tosymra (previously known as DFN-02) by the U.S. Food and Drug Administration (FDA). Tosymra is indicated for the acute treatment of migraine with or without aura in adults. Tosymra is the latest product to join the Promius Pharma acute migraine treatment portfolio. The company is working toward commercialization of this product.

“We are excited about the approval of Tosymra. This approval affirms our ability to develop well-differentiated products to meet the unmet needs of patients with migraine and HCPs treating them,” said G.V. Prasad, Co-Chairman and CEO, Dr. Reddy’s Laboratories.

According to Dr. Anil Namboodiripad, PhD, President, Promius Pharma, “Tosymra nasal spray is formulated using a proprietary novel excipient known as Intravail [®] to achieve blood levels similar to a 4-mg sumatriptan subcutaneous injection, resulting in rapid onset of action. Independent research shows that 26% to 40% of migraine patients are not optimally controlled with their current treatment.  For patients who suffer from the debilitating and disruptive effects of migraine, there continues to be a need for reliable and efficacious treatment options. At Promius, we are committed to developing new ways of improving patient experiences. Tosymra is a mist-like nasal spray that acts rapidly and is well tolerated.”

http://bit.ly/1OqHAzj

FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine

Medicinal Chemistry

Thus Article FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine

That's an article FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine with the link address https://letslifes.blogspot.com/2019/02/fda-approves-tosymra-sumatriptan-nasal.html

Tweet

Subscribe to receive free email updates: